CS logo
small CS logo
Centrum Leczenia Chorób Cywilizacyjnych

Warszawa, Poland
Ortopeda w Warszawie

About Centrum Leczenia Chorób Cywilizacyjnych


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Centrum Leczenia Chorób Cywilizacyjnych


During the past decade, Centrum Leczenia Chorób Cywilizacyjnych conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Centrum Leczenia Chorób Cywilizacyjnych" #1 sponsor was "Amgen" with 1 trials, followed by "Array Biopharma, now a wholly owned subsidiary of Pfizer" with 1 trials sponsored, "Cogentus Pharmaceuticals" with 1 trials sponsored, "Horizon Pharma Ireland, Ltd., Dublin Ireland" with 1 trials sponsored and "IBSA Institut Biochimique SA" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

Clinical Trials Conditions at Centrum Leczenia Chorób Cywilizacyjnych


According to Clinical.Site data, the most researched conditions in "Centrum Leczenia Chorób Cywilizacyjnych" are "Rheumatoid Arthritis" (3 trials), "Diabetes Mellitus, Type 2" (2 trials), "Acute Coronary Syndrome" (1 trials), "Coronary Artery Disease" (1 trials) and "Dental Pain" (1 trials). Many other conditions were trialed in "Centrum Leczenia Chorób Cywilizacyjnych" in a lesser frequency.

Clinical Trials Intervention Types at Centrum Leczenia Chorób Cywilizacyjnych


Most popular intervention types in "Centrum Leczenia Chorób Cywilizacyjnych" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "ARRY-438162, MEK inhibitor; oral" (1 trials), "Apremilast 20 mg" (1 trials), "Apremilast 30 mg" (1 trials) and "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Centrum Leczenia Chorób Cywilizacyjnych


The vast majority of trials in "Centrum Leczenia Chorób Cywilizacyjnych" are 7 trials for "All" genders.

Clinical Trials Status at Centrum Leczenia Chorób Cywilizacyjnych


Currently, there are NaN active trials in "Centrum Leczenia Chorób Cywilizacyjnych". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centrum Leczenia Chorób Cywilizacyjnych, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Leczenia Chorób Cywilizacyjnych, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".